An Open-label Single Arm Phase 2 Proof of Concept Study to Assess the Efficacy and Safety of ASCT01 in Patients With Critical Limb Ischemia

Trial Profile

An Open-label Single Arm Phase 2 Proof of Concept Study to Assess the Efficacy and Safety of ASCT01 in Patients With Critical Limb Ischemia

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs ASCT 01 (Primary)
  • Indications Peripheral ischaemia
  • Focus Therapeutic Use
  • Sponsors Lifecells LLC
  • Most Recent Events

    • 20 Apr 2016 Status changed from recruiting to completed.
    • 21 Jul 2014 Placebo group removed, no of tt. arms changed from 2 to 1, age range changed, study design and official title got changed.
    • 01 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top